亚洲女性较低骨密度对不良心血管疾病的预后价值
该回顾性队列纳入12 681名50-80岁女性,评估骨密度(BMD)对动脉粥样硬化性心血管疾病(ASCVD)的独立及增量预后价值。中位随访9.2年,468名(3.7%)发生ASCVD事件;腰椎、股骨颈和全髋BMD每降低1个标准差,校正后风险比分别为1.16、1.29和1.38(均p<0.001)。骨质疏松临床诊断的校正风险比为1.79(p<0.001),将BMD或骨质疏松诊断加入临床风险因素可显著提升ASCVD事件判别能力。
要点
- 腰椎、股骨颈和全髋BMD降低均独立预测女性ASCVD事件。
- 骨质疏松临床诊断与ASCVD风险升高独立相关(校正HR 1.79)。
- 将全髋BMD加入临床风险因素可显著改善ASCVD风险判别。
核心结论
- BMD评估为女性ASCVD提供独立且增量的预后价值,可能改善女性风险分层。
研究设计与样本
- 回顾性分析12 681名50-80岁(平均63.0±7.8岁)接受双能X线吸收测定法的女性。
- 中位随访9.2年,评估BMD或骨质减少/骨质疏松临床诊断与ASCVD事件的关联,并校正年龄、体质指数、高血压、2型糖尿病、高脂血症、当前吸烟和既往骨折。
主要发现
- 随访期间468名女性(3.7%)发生ASCVD事件(ASCVD死亡、非致死性心肌梗死和缺血性卒中)。
- 腰椎、股骨颈和全髋BMD每降低1个标准差,校正后ASCVD事件风险比分别为1.16(p<0.001)、1.29(p<0.001)和1.38(p<0.001)。
- 骨质疏松临床诊断的校正风险比为1.79(p<0.001)。
- 将BMD或骨质减少/骨质疏松临床诊断加入临床风险因素,对判别ASCVD事件显示显著增量价值(加入全髋BMD的差异p<0.001)。
临床怎么用
- 在50-80岁女性中,可考虑将BMD评估纳入ASCVD风险分层以识别高风险个体。
局限性
- 本研究为回顾性分析,可能存在残余混杂。
- 研究人群为亚洲女性,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We investigated whether the evaluation of bone mineral density (BMD) provides independent and incremental prognostic value for predicting atherosclerotic cardiovascular disease (ASCVD) in women. METHODS: A total of 12 681 women aged 50-80 years (mean, 63.0±7.8 years) who underwent dual-energy X-ray absorptiometry were retrospectively analysed. We assessed the hazard ratio (HR) for ASCVD events (ASCVD death, non-fatal myocardial infarction and ischaemic stroke) according to the BMD or a clinical diagnosis of osteopenia or osteoporosis, with adjustment for clinical risk factors, including age, body mass index, hypertension, type 2 diabetes, hyperlipidaemia, current smoking and previous fracture. We also evaluated whether the addition of BMD or a clinical diagnosis of osteopenia or osteoporosis to clinical risk factors improved the prediction for ASCVD events. RESULTS: In total, 468 women (3.7%) experienced ASCVD events during follow-up (median, 9.2 years). Lower BMD at the lumbar spine, femur neck and total hip was independently associated with higher risk for ASCVD events (adjusted HR per 1-standard deviation decrease in BMD: 1.16, p<0.001; 1.29, p<0.001; 1.38, p<0.001; respectively). A clinical diagnosis of osteoporosis was also independently associated with higher risk for ASCVD events (adjusted HR: 1.79, p<0.001). The addition of BMD or a clinical diagnosis of osteopenia or osteoporosis to clinical risk factors demonstrated significant incremental value in discriminating ASCVD events (addition of total hip BMD, p for difference <0.001). CONCLUSION: The evaluation of BMD provides independent and incremental prognostic value for ASCVD in women and thus may improve risk stratification in women.
引用
- Park J, Yoon YE, Kim KM, et al. Prognostic value of lower bone mineral density in predicting adverse cardiovascular disease in Asian women. Heart. 2021. PMID: 33963047. doi:10.1136/heartjnl-2020-318764
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。